Sandoz Group AG
SDZ
株式のランク
#579
Operating globally, Sandoz Group AG specializes in the development, production,... Operating globally, Sandoz Group AG specializes in the development, production, and distribution of generic medications and biosimilar products. The company's portfolio includes the creation and sale of finished dosage forms for small molecule pharmaceuticals, often supplied to other entities. Sandoz is also a significant player in the biotechnology sector, providing protein-based products such as biosimilars and offering specialized manufacturing services within this field. Furthermore, it supplies anti-infective products, including active pharmaceutical ingredients (APIs) and intermediates, with a strong emphasis on antibiotics. Established in 1886, Sandoz maintains its headquarters in Rotkreuz, Switzerland.
株価
$95.99
時価総額
$41.53B
変化（1日）
0.79%
変化（1年）
58.61%
国
CH
取引 Sandoz Group AG (SDZ)
カテゴリー
Healthcare
Sandoz Group AG（SDZ）のP/B比率
2026 時点のP/B比率 TTM: 0
Sandoz Group AG の最新の財務報告および株価によると、現在のP/B比率（TTM）は 0 です。2026 年末時点でのP/B比率は 0 でした。
Sandoz Group AG の P/B 比率の履歴（2020 ～ 2026）
各年末時点のP/B比率
| 年 | P/B比率 | 変化 |
|---|---|---|
| 2025 | 3.35 | 55.41% |
| 2024 | 2.16 | 13.43% |
| 2023 | 1.90 | -100.00% |
| 2022 | 177.79K | 9,476,858.69% |
| 2021 | 1.88 | -10.92% |
| 2020 | 2.11 | 0.00% |
同業他社のP/B比率
| 企業 | P/B比率 | P/B比率の差 | 国 |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| 1.3124 | - |
JP
|
|
| - | - |
CH
|
|
| 5.041 | - |
IN
|
